This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Mira Rosenblat: Innovator in Lipoprotein Oxidation Inhibition
Introduction
Mira Rosenblat is a prominent inventor based in Halfa, IL. She has made significant contributions to the field of biochemistry, particularly in the area of cardiovascular health. Her innovative work focuses on the inhibition of lipoprotein oxidation, which plays a crucial role in preventing vascular diseases.
Latest Patents
Mira Rosenblat holds 1 patent for her invention titled "Inhibition of lipoprotein oxidation." This patent describes how hydroxylated derivatives of cholesterol-lowering agents can inhibit the oxidation of lipoproteins. This groundbreaking discovery is essential for preventing the progression of atherogenesis and resultant vascular diseases, including heart attacks.
Career Highlights
Throughout her career, Mira has worked with the Warner-Lambert Company, where she has been able to apply her research to real-world applications. Her dedication to advancing medical science has made her a respected figure in her field.
Collaborations
Mira has collaborated with notable colleagues, including Michael Aviram and Charles Larry Bisgaier. These partnerships have further enhanced her research and contributed to the advancement of knowledge in the area of lipoprotein oxidation.
Conclusion
Mira Rosenblat's innovative work in the inhibition of lipoprotein oxidation has the potential to significantly impact cardiovascular health. Her contributions to science and collaboration with esteemed colleagues highlight her importance in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile